-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1506.pdf
June 01, 2015 - Treatments are aimed at symptomatic relief, but questions of safety and efficacy
remain. … However, other experts
thought the availability of a new IBS therapy with a seemingly good safety profile … Salix's TARGET 3 study examines the safety and
efficacy of repeat treatment with rifaximin 550 mg … -550
http://news.salix.com/press-release/salixs-target-3-study-examines-safety-and-efficacy-repeat-treatment-rifaximin … -550
http://news.salix.com/press-release/salixs-target-3-study-examines-safety-and-efficacy-repeat-treatment-rifaximin
-
effectivehealthcare.ahrq.gov/sites/default/files/s96.pdf
October 01, 2007 - Findings
from NEISS-CADES can help design and prioritize patient safety
interventions for outpatient … Commission before dissemination of
results to patients, clinicians, and public health practitioners. … In
February and March 2006, 2 FDA Drug Safety Advisory
Panels addressed the safety of stimulant drugs … Con-
sumer Product Safety Commission; March 2000.
10. … Adverse drug events
in emergency department patients. Ann Emerg Med. 2002;39:258–267.
28.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-256-telehealth-women-disposition-comments.pdf
June 16, 2022 - reported outcomes, patient satisfaction in care and patient adherence
to visits via telehealth approaches … decision aid rather than
safety planning? … Both qualitative and
patient reported outcomes are
included. … The outcomes is increased use of helpful safety
behaviors, not simply increase use of safety behaviors … Patients boycotted.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/crohns-disease_executive.pdf
February 01, 2014 - • Other infections
• Infusion- and injection-site reactions
• Bone fractures
• Height and weight as indicators … on
groups of medications); and (3) clear numerators (patients
who experienced the safety event of … Most patient-reported outcomes
were measured by the IBDQ. … The studies that included all
inflammatory bowel disease patients had safety findings
similar to those … Safety and tolerability of
concurrent natalizumab treatment for patients with Crohn’s disease
not in
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/engaging-caregivers-rapid-review.pdf
April 01, 2024 - What patient safety measures or indicators have been used to examine these harms?
3. … safety
measures or indicators. … safety measures,
AHRQ’s Patient Safety Indicators, or the National Committee for Quality Assurance … What Patient Safety Measures or
Indicators Have Been Used To Examine These Harms? … Research and Quality (AHRQ) Patient Safety
Measures measures or indicators do not specifically address
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/public-reporting-quality-improvement_research-protocol.pdf
August 17, 2011 - Reduced patient engagement and/or negative outcomes if patients believe, based on a
report, that they … automated reminders, staff capacity) in an effort to improve their
performance on the outcomes or indicators … myhealthcareadvisor or Massachusetts Health
Quality or (Pennsylvania adj3 coronary) or (Hospital Quality adj2
Safety … We will also contrast and summarize results by other
groupings (e.g., report format or the quality indicators … Studies that include cost-effectiveness among reported indicators or that look at an outcome
with resource
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/crohns-disease_research-protocol.pdf
September 01, 2010 - Over time, 73% of patients will have a
relapsing and remitting course, while only 10% of patients will … Our proposal will address these aims, as well as the safety and patient-reported
outcomes representing … We aim to compare the effectiveness, safety and patient-reported outcomes
representing quality of life … The patient-reported outcomes will also help patients and caregivers to take into
consideration the … Objectives
We aim to compare the effectiveness, safety and patient-reported measures of individual
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/recombinant-factor-viia_clinician.pdf
October 01, 2010 - . ���
Increased risk for arterial thromboembolic
events, particularly at doses >40 µg/kg of
patient … though the effect of treating spontaneous intracranial hemorrhage with rFVIIa at doses ≤40 μg/kg of patient … rFVIIa) in the hospital setting has increased despite limited comparative data
on its effectiveness and safety … How is it being used, and what is the evidence of benefits and harms for treated patients? … In-Hospital, Off-Label Use of rFVIIa
TE Events/Total Patients
(%)
Risk Difference Summary
Effect Size
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-update-surv-rep-3.pdf
January 01, 2023 - Cannabis
for chronic pain: cardiovascular safety in a
nationwide Danish study. … Pharmacokinetics and pharmacodynamics of
cannabis-based medicine in a patient population
included in … Medicinal cannabis for Australian patients with chronic
refractory pain including arthritis.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-anemia-update_research-protocol.pdf
June 16, 2010 - The 2006 CER revealed safety concerns for the erythropoietic stimulants as a
class. … In an individual patient data meta-analysis of 13,933 patients in 53 trials
treated with epoetin alfa … analyzed individual patient data from 2,122 patients in 6 trials receiving darbepoetin
alpha finding … Study and Independent Patient Level Meta-Analysis Selection:
Results from study- and patient-level meta-analysis … Erythropoietin or Darbepoetin for
patients with cancer--meta-analysis based on individual patient data
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1406.pdf
September 26, 2014 - for calibrating the
CGM (as applicable) and checking sensor performance as needed plus associated
reagents … Patients and
their diabetes care teams work to adjust patient insulin dosages using feedback from a … health
outcomes, citing safety concerns and limited efficacy data. … Summary of safety and effectiveness data
(SSED). MiniMed 530G system. P120010. … Efficacy and safety of insulin degludec in a
flexible dosing regimen vs insulin glargine in
patients
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_disposition-comments.pdf
April 25, 2013 - or specific patient populations since
there is evidence that certain groups of patients may not
necessarily … However, that group was part of
the patient population defined for the review. … more in this manuscript because it is relevant to clinical practice and
it is the reason for ongoing safety … measures in accordance
with the AHRQ Methods Guide, these data are clinically important to consider for
safety … Since the 2008 ODAC meeting,
there have been no new safety signals that would warrant the conclusion
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-205-predictors-trauma-care-disposition-comments.pdf
April 01, 2018 - These sites also need some type of triage scheme to
determine if a patient needs to go to a higher level … We have expanded the
explanation that we used several
indicators for serious injury in this
review … Very different from triage of daily occurring injuries where focus is on
a single patient. … We agree that using different
indicators of serious injury effects
the performance and we included … Doing so increases costs and risks
to personal safety.
-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1506.pdf
June 01, 2015 - abuse by increasing the
perceived safety of a harmful behavior. … Commercial clients pay
annual licensing fees for CaringTXT, prorated on projected patient populations … CaringTXT annual licenses cost about $12,000 to $18,000 for an average-sized university or
college client … Across all client types, patients pay for text messages only if the service is not included
in their … As of June 2015, CaringTXT was in use by clients including
the University of Pittsburgh and the Central
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/vaccine-safety_research-protocol.pdf
September 18, 2012 - System
(VAERS),11 the Vaccine Safety Datalink,12 and the Clinical Immunization Safety Assessment
Network … Both
patient factors (i.e., age and race) and vaccine factors (i.e., formulation, dosage, and timing … AEs) or passive (participants are not specifically asked about or tested for the
occurrence of AEs; patient … Multiple publications are defined by the investigated patients.
F. … The Vaccine Safety Datalink: a model for monitoring
immunization safety.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-195-disposition-comments-uterine-fibroids.pdf
December 14, 2017 - Due to safety issues, the
use of leuprolide is limited for only 3 months. … bleeding and statistically significant improvements in
women’s symptom and health-related quality-of-life indicators … had
much less time to get pregnant than the myomectomy patients. … US patients are different than European (or other
patients) in that there is greater direct appeal by … pharma,
device companies and providers to the consumer (patient).
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs4-infection-prevention-mdro-rapid-research.pdf
April 01, 2024 - What patient safety measures or indicators have been used to
examine the frequency and severity of healthcare-associated … What patient safety measures or indicators have been used to examine the
frequency and severity of … safety measures or
indicators. … safety
measures, AHRQ’s Patient Safety Indicators, or the National Committee for Quality
Assurance … What Patient Safety Measures or
Indicators Have Been Used To Examine the Frequency and
Severity of
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/lifecycle-assessment-protocol.pdf
August 23, 2023 - safety. … care
and safety.14 The focus on patient safety has led to a rise in single-use devices and a
planned … What data sources, measures/indicators, and methods were used in
the analysis?
iii. … Balancing Infection Control and Environmental Protection as
a Matter of Patient Safety: The Case of … Key Informants
Key Informants are the end users of research, including patients and caregivers,
practicing
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/uterine-fibroids_research-protocol.pdf
March 01, 2016 - including MRgFUS systems and power morcellators (see Table
A-2 in Appendix), though it has issued safety … and tumor characteristics that may
predict success or adverse events in patients considered for morcellation … Examples
include: baseline characteristics of the patients (e.g., age, menopausal status; symptom
status … Laparoscopic Uterine Power Morcellation in
Hysterectomy and Myomectomy: FDA Safety Communication, Updated … Available at
http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm424443.htm.
19.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs4-infection-prevention-mdro-protocol.pdf
July 01, 2023 - What patient safety measures or indicators have been used to examine the frequency and severity of … What patient safety practices have been used to prevent or mitigate the harms of healthcare-associated … What are the most common barriers and facilitators of implementing the patient safety practices? … What toolkits are available to support implementation of the patient safety practices? … stakeholders, clinical specialists,
experts in patient safety issues, and a patient/consumer perspective